A balanced translocation disrupts SYNGAP1 in a patient with intellectual disability, speech impairment, and epilepsy with myoclonic absences (EMA)
- PMID: 22050443
- DOI: 10.1111/j.1528-1167.2011.03304.x
A balanced translocation disrupts SYNGAP1 in a patient with intellectual disability, speech impairment, and epilepsy with myoclonic absences (EMA)
Abstract
Epilepsy with myoclonic absences (EMA) is a rare form of generalized epilepsy occurring in childhood and is often difficult to treat. The underlying etiology of EMA is unknown in the majority of patients. Herein, we describe a patient with EMA and intellectual disability who carries a de novo balanced translocation: t(6;22)(p21.32;q11.21). We mapped the translocation breakpoints by fluorescence in situ hybridization (FISH), and the breakpoint at 6p21.32 was found to truncate the N-methyl-d-aspartate (NMDA)-receptor associated gene SYNGAP1. The breakpoint at 22q11.21 was within a highly variable region without known protein-coding genes. Mutations of SYNGAP1 are associated with nonsyndromal intellectual disability (NSID). Two-thirds of the patients described so far also have generalized epilepsy. This finding, together with our report, suggests that dysfunction of SYNGAP1 contributes to the development of generalized epilepsy, including EMA.
Wiley Periodicals, Inc. © 2011 International League Against Epilepsy.
Similar articles
-
6p21.3 microdeletion involving the SYNGAP1 gene in a patient with intellectual disability, seizures, and severe speech impairment.Am J Med Genet A. 2013 Jul;161A(7):1682-5. doi: 10.1002/ajmg.a.35930. Epub 2013 May 17. Am J Med Genet A. 2013. PMID: 23687080
-
Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency.Hum Mutat. 2013 Feb;34(2):385-94. doi: 10.1002/humu.22248. Epub 2012 Dec 12. Hum Mutat. 2013. PMID: 23161826
-
De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism.Biol Psychiatry. 2011 May 1;69(9):898-901. doi: 10.1016/j.biopsych.2010.11.015. Epub 2011 Jan 15. Biol Psychiatry. 2011. PMID: 21237447
-
SYNGAP1 mutations: Clinical, genetic, and pathophysiological features.Int J Dev Neurosci. 2019 Nov;78:65-76. doi: 10.1016/j.ijdevneu.2019.08.003. Epub 2019 Aug 24. Int J Dev Neurosci. 2019. PMID: 31454529 Review.
-
Novel SYNGAP1 variant in a patient with intellectual disability and distinctive dysmorphisms.Congenit Anom (Kyoto). 2018 Nov;58(6):188-190. doi: 10.1111/cga.12273. Epub 2018 Feb 13. Congenit Anom (Kyoto). 2018. PMID: 29381230 Review.
Cited by
-
Genetic and epigenetic mechanisms of epilepsy: a review.Neuropsychiatr Dis Treat. 2017 Jul 13;13:1841-1859. doi: 10.2147/NDT.S142032. eCollection 2017. Neuropsychiatr Dis Treat. 2017. PMID: 28761347 Free PMC article. Review.
-
Two knockdown models of the autism genes SYNGAP1 and SHANK3 in zebrafish produce similar behavioral phenotypes associated with embryonic disruptions of brain morphogenesis.Hum Mol Genet. 2015 Jul 15;24(14):4006-23. doi: 10.1093/hmg/ddv138. Epub 2015 Apr 16. Hum Mol Genet. 2015. PMID: 25882707 Free PMC article.
-
Identification of an individual with a SYGNAP1 pathogenic mutation in India.Mol Biol Rep. 2020 Nov;47(11):9225-9234. doi: 10.1007/s11033-020-05915-4. Epub 2020 Oct 22. Mol Biol Rep. 2020. PMID: 33090308
-
SYNGAP1 encephalopathy: A distinctive generalized developmental and epileptic encephalopathy.Neurology. 2019 Jan 8;92(2):e96-e107. doi: 10.1212/WNL.0000000000006729. Epub 2018 Dec 12. Neurology. 2019. PMID: 30541864 Free PMC article.
-
Candidate Genes for Eyelid Myoclonia with Absences, Review of the Literature.Int J Mol Sci. 2021 May 25;22(11):5609. doi: 10.3390/ijms22115609. Int J Mol Sci. 2021. PMID: 34070602 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials